These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11310528)

  • 1. Colestipol-induced hepatotoxicity.
    Sirmans SM; Beck JK; Banh HL; Freeman DA
    Pharmacotherapy; 2001 Apr; 21(4):513-6. PubMed ID: 11310528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute liver injury associated with glucosamine dietary supplement.
    Ebrahim V; Albeldawi M; Chiang DJ
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23239775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colestipol granules in the colon: macroscopic and microscopic findings.
    Gonzalez RS; Schwartz DA; Shi C
    Histopathology; 2015 Jul; 67(1):141-2. PubMed ID: 25406854
    [No Abstract]   [Full Text] [Related]  

  • 4. Low dose colestipol in adolescents with familial hypercholesterolaemia.
    Tonstad S; Sivertsen M; Aksnes L; Ose L
    Arch Dis Child; 1996 Feb; 74(2):157-60. PubMed ID: 8660081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining patient risks from expanded preventive therapies.
    Tolman KG
    Am J Cardiol; 2000 Jun; 85(12A):15E-9E. PubMed ID: 10858489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia.
    McCrindle BW; Helden E; Cullen-Dean G; Conner WT
    Pediatr Res; 2002 Jun; 51(6):715-21. PubMed ID: 12032266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
    Weisweiler P; Merk W; Jacob B; Schwandt P
    Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.
    Perlemuter G; Cacoub P; Valla D; Guyader D; Saba B; Batailler C; Moore K
    CNS Drugs; 2016 Sep; 30(9):877-88. PubMed ID: 27342740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary tuberculosis with chemotherapy related liver dysfunction].
    Yasuda K; Sato A; Chida K; Shichi I; Kishimoto H; Wada R; Tatsuta Y; Honda A; Yamazaki A
    Kekkaku; 1990 Jun; 65(6):407-13. PubMed ID: 2388450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Transaminases with Topical Diclofenac: A Case Report.
    Daniels AM; Gibbs LM; Herndon CM
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):161-164. PubMed ID: 30645151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia.
    Fellin R; Briani G; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    Atherosclerosis; 1975; 22(3):431-45. PubMed ID: 1201145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemoline hepatotoxicity in children.
    Marotta PJ; Roberts EA
    J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver.
    Hedrington MS; Davis SN
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):671-677. PubMed ID: 29847748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia.
    Spence JD; Huff MW; Heidenheim P; Viswanatha A; Munoz C; Lindsay R; Wolfe B; Mills D
    Ann Intern Med; 1995 Oct; 123(7):493-9. PubMed ID: 7661492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colestipol hydrochloride prophylaxis of diarrhea during pelvic radiotherapy.
    Stryker JA; Chung CK; Layser JD
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):185-90. PubMed ID: 6833021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colestipol tablets in adolescents with familial hypercholesterolaemia.
    Tonstad S; Ose L
    Acta Paediatr; 1996 Sep; 85(9):1080-2. PubMed ID: 8888922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.